NEUROPATHIC OCULAR PAIN MARKET ANALYSIS

Neuropathic Ocular Pain Market, By Drug Class (Steroids, Non-Steroidal Anti-Inflammatory Drugs, Antidepressants, Anticonvulsants, Opioids, and Others (Vitamin B supplements, Botulinum toxin A, and others)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), And by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Mar 2023
Code : CMI5600
Pages :170
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Major players operating in the global neuropathic ocular pain market include OKYO Pharma, Limited, Ocular Therapeutix, Inc., IACTA Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd., Novartis AG, SALVAT, AbbVie Inc., Bausch & Lomb Incorporated, Kala Pharmaceuticals, Spectra Vision Care, Alcon Laboratories, AERIE PHARMACEUTICALS, INC., Optocred Pharmaceuticals and BRIM Biotechnology, Inc.

Neuropathic Ocular Pain Market Report Snapshots